Clinical Research Directory
Browse clinical research sites, groups, and studies.
Zimmer® Natural Nail® (ZNN) Bactiguard Tibia Post-Market Clinical Follow-up Study
Sponsor: Zimmer Biomet
Summary
Primary objective of this study is to compare fracture related infection (FRI) rates of ZNN Bactiguard Tibia to conventional uncoated titanium-alloy nails 12 months after tibia fracture fixation. The secondary objectives are confirmation of safety, performance and clinical benefits of ZNN Bactiguard implant and related instrumentation12 months after fracture fixation.
Official title: Performance, Safety and Clinical Benefits of a Noble Metal Alloy-coated Intramedullary Nail: a Multicenter, Prospective Trial With a Retrospective Control
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2022-04-11
Completion Date
2027-07
Last Updated
2025-11-25
Healthy Volunteers
No
Conditions
Interventions
ZNN Bactiguard tibia
Tibia fracture fixation
Locations (16)
Tirolkliniken Innsbruck
Innsbruck, Austria
Hôpital Ambroise-Paré
Boulogne-Billancourt, France
Hôpitaux Universitaires de Marseille Nord
Marseille, France
Universitätsklinikum Marburg
Marburg, Hesse, Germany
Universitätsklinikum Leipzig
Leipzig, Germany
Universitätsklinikum Regensburg
Regensburg, Germany
AOU Policlinico di Bari
Bari, Italy
Azienda Ospedaliero-Universitaria Careggi
Florence, Italy
Tygerberg Hospital
Cape Town, South Africa
Groote Schuur Hospital
Cape Town, South Africa
Hospital Universitario Valle de Hebrón
Barcelona, Catalonia, Spain
Kantonsspital Winterthur
Winterthur, Canton of Zurich, Switzerland
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom
Leeds General Infirmary
Leeds, United Kingdom
The Royal London Hospital
London, United Kingdom
King's College Hospital NHS Trust
London, United Kingdom